GnRH-antagonism—cetrorelix produced rapid anti-inflammatory effects in terms of decreased TNF-α, IL-1β, IL-10, and CRP compared with placebo in RA patients with high gonadotropin levels [149]. Here, GNRH1 is linked to rheumatoid arthritis.